How Bone Disease Is Related to Kidney Function
Renal osteodystrophy, a condition stemming from kidney dysfunction, affects the majority of dialysis patients and emerges early in chronic kidney disease stages 3–4. Without proper treatment, bones gradually weaken and become less dense, resulting in bone and joint discomfort and heightened fracture risk.
Hormones and Minerals
Healthy adults experience continuous bone remodeling and rebuilding. The kidneys regulate calcium, phosphorus, and vitamin D levels. Your kidneys convert vitamin D into its active form and maintain ongoing communication with the parathyroid gland in the neck. These functions progressively decline as kidney disease advances.
Diagnosis
Doctors diagnose renal osteodystrophy by measuring blood levels of calcium, phosphorus, vitamin D, and parathyroid hormone (PTH). Occasionally, a bone biopsy may assess bone density. Identifying the underlying cause helps guide treatment decisions.
Treatment
Managing calcium, vitamin D, phosphorus, and PTH levels through dietary modifications and medications represents the initial approach.
Phosphorus reduction is crucial for preventing bone disease. While most foods contain phosphorus, it concentrates heavily in milk, cheese, legumes, nuts, cocoa, and dark sodas. Food preservatives often contain high phosphorus levels.
Some kidney patients require activated vitamin D (calcitriol) rather than standard vitamin D to maintain adequate bone density.
Exercise strengthens bones in certain patients. Poor management can lead to hyperparathyroidism, requiring medication. Regular nephrologist visits with timely blood work help prevent complications.